AspenBio Pharma (APPY) has been ripping higher in recent days, as investors await trial results for their flagship AppyScore, a blood-based test designed to aid in the evaluation of appendicitis, expected during the first week of May. Shares are up 50 cents to $3.80 and have rallied more than 50 percent on the week. Options activity has picked up with each day as well. 180 calls traded Monday, 81 Tuesday, 1,700 Wednesday, 1,820 Thursday, and 2,030 so far today. The action today is in the June and May 5 calls, with some investors buying to open positions ahead of the results. Implied volatility, which jumped from 122 to 217 Tuesday through Thursday, has eased back towards 200.
Looking for more updates like this, including unusual actions activity, bullish/bearish flow, and trading ideas? Please visit our FAQs page to learn more about WhatsTrading.com. In addition to continuous updates straight from the options market, we also offer visual recap charts (put-call volume, put-to-call ratios, and open interest) with each update, the opportunity to post questions and get answers from experienced options pros, and also get real-time data and commentary via Flow Monitor. Please register to find out more about WhatsTrading.com Premium and our new Flow Monitor. Please contact support if you have any questions.